ABSTRACT
The accuracy of forensic age estimation based on the chronology of second (M2) and third molar (M3) development was investigated using 2,087 orthopantomograms of Korean men and women aged between 3 and 23 years. The developmental stages of M2s and M3s in these subjects were classified using the criteria of Demirjian. Inter-observer reliability and statistical data on each stage of mineralization of M2s and M3s were evaluated. The left-right symmetries of the maturation degrees in the M2s and M3s were observed in both sexes, between which no arch differences were found, but statistically significant sex-specific differences were observed in some stages of M2 and M3 development. In multiple regression analysis, a strong positive relationship was observed between age and mineralization of M2s and M3s. The regression formulas for estimating the age of Koreans were presented based on sex and combination of teeth. These results suggest that the developments of second and third molars can be considered as valuable age indicators in Korean adolescents and young adults.
Subject(s)
Age Determination by Teeth/methods , Forensic Dentistry/methods , Forensic Dentistry/statistics & numerical data , Molar/growth & development , Adolescent , Adult , Asian People , Child , Child, Preschool , Female , Humans , Male , Molar, Third/growth & development , Regression Analysis , Young AdultABSTRACT
BACKGROUND: Botulinum toxin type A (BTX-A) has been applied successfully to treat masseteric hypertrophy, but it can cause muscle weakness. OBJECTIVE: To measure the change in maximum bite force (MBF) after BTX-A injection into the human masseter muscle and to evaluate the influence of a booster (repeated) injection. METHODS: Thirty volunteers completed 18-week follow-up, and MBF was measured. At 18 weeks after the first injection, a booster injection was given to 14 patients, and they were followed up until 18 weeks from the booster injection. RESULTS: Mean MBF was approximately 20% lower at 2 weeks than before the injection, and it recovered gradually after 4 weeks to return to the preinjection level at 12 weeks. MBF differed significantly between before the injection and at 2, 4, and 8 weeks after the injection (p<.05). In the booster injection group (n=14), MBF was markedly lower at 6 weeks (p<.05), and it recovered gradually in 12 weeks. CONCLUSION: MBF was significantly lower after booster injection of BTX-A into the human masseter muscle, but it gradually recovered in a predictable pattern, and the degree of discomfort experienced by the subjects had little effect on normal mastication.
